The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse

Neuroscience

Volumn 124, Issue 4, 2004, Pages 945-952

  Abraham, K E ^a   Mcmillen, D ^b   Brewer, K L ^b  

^a SHENANDOAH UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

; Autotomy; IL 10; Inflammation; Interleukin 10; Knock out; Neuroprotection; Neutrophils; PBS; Phosphate buffered saline; QUIS; Quisqualic acid; Recombinant murine; rm; SCI; Spinal cord injury; Wild type; WT

Indexed keywords

INTERLEUKIN 10; QUISQUALIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GRAY MATTER; IMMUNE RESPONSE; LOW DRUG DOSE; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; TISSUE INJURY; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD CELL COUNT; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PAIN; PERIAQUEDUCTAL GRAY; SPINAL CORD DISEASES;

EID: 1542291023     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.01.004     Document Type: Article

References (51)

1. Abraham K.E., Brewer K.L., McGinty J.F. Opioid peptide mRNA expression following excitotoxic spinal cord injury. Neuroscience. 99:2000;189-197.
2. Abraham K.E., McGinty J.F., Brewer K.L. Opioid peptide mRNA expression is related to the onset of pain-related behaviors following excitotoxic spinal cord injury. Pain. 90:2001;181-190.
3. Abraham K.E., McGinty J.F., Brewer K.L. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury. Neuroscience. 104:2001;863-874.
4. Anderson R. The activated neutrophil- formidable forces unleashed. S Afr Med J. 85:1995;1024-1028.
5. Balasingham V., Yong V.W. Attentuation of astroglial activity by interleukin-10. J Neurosci. 16:1996;2945-2955.
6. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rats that produces disorders of pain sensation like those seen in human. Pain. 33:1988;87-107.
7. Berkman N., John M., Roesems G., Jose P.J., Barnes P.J., Chung K.F. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10 Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol. 155:1995;4412-4418.
8. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma. 16:1999;851-863.
9. Blight A.R. Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J Neurol Sci. 103:1991;156-171.
10. Bracken M.S., Shepard M.J., Holford T.R., Leo-Summers L., Aldrich E.F., Fazl M., Fehlings M.G., Herr D.L., Hitchon P.W., Marshall L.F., Nockels R.P., Pascale V., Perot P.L. Jr, Piepmeier J., Sonntag V.K., Wagner F., Wilberger J.E., Winn H.R., Young W. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury 1-year follow up; results of the third national acute spinal cord injury randomized controlled trial. J Neurosurg. 89:1998;699-706.
11. Brewer K.L., Bethea J.R., Yezierski R.P. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol. 159:1999;484-493.
12. Carlson S.L., Parrish M.E., Springer J.E., Doty K., Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol. 151:1998;77-88.
13. Cassatella M.A. The neutrophil One of the cellular targets of interleukin-10. Int J Clin Lab Res. 28:1998;148-161.
14. Chmiel J.F., Konstan M.W., Saadane A., Krenicky J.E., Lester Kirchner H., Berger M. Prolonged inflammatory response to acute pseudomonas challenge in interleukin-10 knockout mice. Am J Respir Crit Care Med. 165:2002;1176-1181.
15. Christensen M.D., Everhart A.W., Pickelman J.T., Hulsebosch C.E. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain. 68:1996;97-107.
16. Crisi G.M., Santambrogio L., Hochwald G.M., Smith S.R., Carlino J.A., Thorbecke G.J. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis Protection by transforming growth factor-beta and interleukin-10. Eur J Immunol. 2:1995;3035-3040.
17. Cunha F.Q., Moncada S., Liew F.Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun. 182:1992;1155-1159.
18. de Castro R. Jr, Burns C.L., McAdoo D., Romanic A.M. Metalloproteinase increases in the injured rat spinal cord. Neuroreport. 11:2000;3551-3554.
19. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci. 6:1994;712-724.
20. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 147:1991;3815-3822.
21. Fiorentino DF, Zlotnik A, Viera P, Mosmann TR, Howard M, Moore KW, O'Garra (1991b) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells J Immunol 146:3444-3451.
22. Gheng Y., Gulbins E., Altman A., Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc Natl Acad Sci USA. 91:1994;8602-8606.
23. Gorman A.L., Yu C.-G., Ruenes G.R., Daniels L., Yezierski R.P. Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury. J Pain. 2:2001;229-240.
24. Hao J.-X., Xu X.-J., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z. Allodynia-like effects in rat after ischemic spinal cord injury photochemically induced by laser irradiation. Pain. 45:1991;175-185.
25. Laughlin T.M., Bethea J.R., Yezierski R.P., Wilcox G.L. Cytokine involvement in dynorphin-induced allodynia. Pain. 84:2000;159-167.
26. Levitt M. Dysesthesias and self-mutilation in humans and subhumans A review of clinical and experimental studies. Brain Res. 10:1985;247-290.
27. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 19:2001;683-765.
28. Noble L.J., Donovan F., Igarashi T., Goussev S., Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 22:2002;7526-7535.
29. Okamoto K., Martin D.P., Schmelzer J.D., Mitsui Y., Low P.A. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol. 169:2001;386-391.
30. Plunkett J.A., Yu C.G., Easton J.M., Bethea J.R., Yezierski R.P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury. Exp Neurol. 168:2001;144-154.
31. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol. 377:1997;443-464.
32. Rongione A.J., Kusske A.M., Ashley S.W., Reber H.A., McFadden D.W. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. J Surg Res. 70:1997;107-112.
33. Schwab M.E., Bartholdi D. Degeneration and regeneration of axons within the lesioned spinal cord. Physiol Rev. 76:1996;319-370.
34. Sewnath M.E., Olszyna D.P., Birjmohun R., ten Kate F.J., Gouma D.J., van Der Poll T. IL-10 deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol. 166:2001;6323-6331.
35. Shappell S.B., Smith C.W. Acute inflammatory response: granulocyte migration and activation. Wegner C.S. The handbook of immunopharmacology: adhesion molecules. 1994;29-70 Academic Press, Abbott Park, IL.
36. Siddall P., Xu C.L., Cousins M. Allodynia following traumatic spinal cord injury in the rat. Neuroreport. 6:1995;1241-1244.
37. Takami T., Oudega M., Bethea J.R., Wood P.M., Kleitman N., Bunge M.B. Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma. 19:2002;653-666.
38. Taoka Y., Okajima K., Uchiba M., Murakami K., Kushimoto S., Johno M., Naruo M., Okabe H., Takatsuki K. Role of neutrophils in spinal cord injury in the rat. Neuroscience. 79:1997;1177-1182.
39. Tonai T., Shiba K., Taketani Y., Ohmoto Y., Murata K., Muraguchi M., Ohsaki H., Takeda E., Nishisho T. A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J Neurochem. 78:2001;1064-1072.
40. Tu H., Juelich T., Smith E.M., Tyring S.K., Rady P.L., Hughes T.K. Jr. Evidence for endogenous interleukin-10 during nociception. J Neuroimmunol. 139:2003;145-149.
41. Vale M.L., Marques J.B., Moreira C.A., Rocha F.A., Ferreira S.H., Poole S., Cunha F.Q., Ribeiro R.A. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J Pharmacol Exp Ther. 304:2003;102-108.
42. Van Scott M.R., Justice J.P., Bradfield J.F., Enright E., Sigounas A., Sur S. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am J Physiol Lung Cell Mol Physiol. 278:(L667-):2000;674.
43. Vierck C.J. Jr. Can mechanisms of central pain syndromes be investigated in animal models? Casey K.L. Pain and central nervous system disease: the central pain syndromes. 1991;129-141 Raven Press, New York.
44. Wagner R., Janjigian M., Myers R.R. Anti-inflammatory interleukin-10 in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-α expression. Pain. 74:1998;35-42.
45. Woessner J.F. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
46. Yezierski R.P., Park S.H. The mechanosensitivity of spinal neurons following intraspinal injections of quisqualic acid in the rat. Neurosci Lett. 157:1993;115-119.
47. Yezierski T.P., Santana M., Park D.H., Madsen P.W. Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat. J Neurotrauma. 10:1993;445-456.
48. Yezierski R.P., Liu S., Ruenes G.L., Kajander K.J., Brewer K.L. Behavioral and pathological characteristics of a central pain model following spinal injury. Pain. 75:1998;141-155.
49. Zeltser R., Seltzer Z. A practical guide for the use of animal models in the study of neuropathic pain. Boivie J., Hansson P., Lindblom U. Touch, temperature and pain in health and disease: mechanisms and assessments progress in pain research management, Vol. 3. 1994;295-338 IASP Press, Seattle, WA.
50. Zhang Z., Krebs C.J., Guth L. Experimental analysis of progressive necrosis after spinal cord trauma in the rat Etiological role of the inflammatory response. Exp Neurol. 143:1997;141-152.
51. Zou X.M., Yagihashi A., Hirata K., Tsuruma T., Matsuno T., Tarumi K., Asanuma K., Watanabe N. Downregulation of cytokine-induced neutrophil chemoattractant and prolongation of rat liver allograft survival by interleukin-10. Surg Today. 28:1998;184-191.